Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia
Clinical trial NCT02998645 · COMPLETED
Trial details
- NCT number
- NCT02998645
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2020-11-03
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.